2025 Regenerative Medicine Summit: Advanced Cell Therapy
【Event Announcement】2025 Regenerative Medicine Summit: Advanced Cell Therapy
Launching on December 5 — Spotlighting Global Frontiers in Cell Therapy and Regenerative Medicine
Co-hosted by Ustar Biotech Co., Ltd. and the Development Center for Biotechnology (DCB), the 2025 Regenerative Medicine Summit: Advanced Cell Therapy will take place on Friday afternoon, December 5, 2025, during Day 2 of the Taipei International Healthcare & Medical Exhibition, at TaiNEX 1 Hall 1. This year’s summit centers on Advanced Cell Therapy, highlighting cutting-edge advancements in regenerative medicine and cell-based therapeutics. The event brings together world-leading experts from industry, academia, and clinical practice to explore key topics including technological innovation, clinical translation, manufacturing quality, and global industry strategies, fostering new momentum for the future of regenerative medicine.Global Thought Leaders Converge to Share Insights on the Future of Medicine
Yu-Fen Chang, Ph.D.
Founder & CEO, Ustar Biotech
A pioneer in iPSC platform development and clinical translation, Dr. Chang has built an integrated pipeline spanning disease modeling, high-throughput drug screening, and functional cell therapy. She will discuss how functional cells × functional quality control can make cellular functionality measurable and accelerate iPSC clinical applications.
Miguel Forte, MD, PhD
President, ISCT / CEO, Kiji Therapeutics
A global leader in cell therapy and regulatory strategy, Dr. Forte will present insights on the current landscape of Cell & Gene Therapy (CGT), major challenges in clinical translation, and actionable strategies to advance therapy commercialization.
Seiji Hori, Ph.D.
CTO, VC Cell Therapy / Executive Director, iPS Portal
A key figure in Japan’s regenerative medicine ecosystem, Dr. Hori will share updates on Japan’s iPSC clinical translation, international collaboration opportunities, and strategic perspectives on Asia’s regenerative medicine growth.
Shin Kawamata, MD, PhD
Senior Executive Advisor, Cyto-Facto / Specially Appointed Professor, Kobe University
A leading architect of iPSC manufacturing standardization in Japan, Dr. Kawamata will introduce Quality by Design (QbD)-based manufacturing approaches and discuss how pharmaceutical-grade methodologies can enhance cell and gene therapy development.
S. Joseph Huang, MD, PhD
Vice Superintendent, E-Da Dachang Hospital / Professor, E-Da School of Medicine
An expert in gynecology and regenerative medicine, Dr. Huang will present clinical findings on the application of ADSC-CM (Adipose-Derived Stem Cell Conditioned Medium) for treating endometriosis, opening new avenues for regenerative gynecological therapy.
A Cross-Disciplinary Platform for Regenerative Medicine Collaboration
From scientific breakthroughs to clinical implementation, and from manufacturing innovation to international strategy, the summit provides a comprehensive view of the regenerative medicine ecosystem. In-depth discussions among leading experts will advance collaboration between Taiwan’s regenerative medicine sector and global clinical practice.
Event Details
Date & Time: Friday, December 5, 2025, 1:30 PM
Venue: Meeting Room 404, TaiNEX 1, Taipei
Language: English
Organizers: Ustar Biotech Co., Ltd.; Development Center for Biotechnology (DCB)
Co-organizers: E-Da Hospital; Taiwan Bio Industry Organization (TBIO)
Registration: 2025 Regenerative Medicine Summit: Advanced Cell Therapy
